Stock Markets Analysis & Opinion

Genticel: Mixed Fortunes  
By Edison - Feb 10, 2016

Genticel (PA:GTCL) has announced the Phase II results of its GTL001 vaccine to treat early-stage human papillomavirus 16 and 18 (HPV 16 and 18) infections. The primary 12-month endpoint, focused on ...

Terry Grennon
Global Stock Prices 16% Off Peak
By Terry Grennon - Feb 10, 2016

Below are yesterday’s closing prices … followed by some key prices tied to global stocks. US Stocks: Measured by market capitalization- SPDR S&P 500 ETF (N:SPY): Critical Support: ...

Michael Filighera
ES: Is There A Wow Factor?
By Michael Filighera - Feb 10, 2016

The answer to the title question is an unequivocal “Yes.” It could be the widening of your eyes in amazement as the ES trades in a 20 to 30-point range both to the downside and upside in ...

Warren Bevan
Markets Look To Be In A Consolidation Phase
By Warren Bevan - Feb 10, 2016

"If you want to achieve greatness stop asking for permission." Anonymous We started off with some weakness, then saw strength, then weakness, where real-time members and I covered our Facebook Inc ...

Michael T. Snyder
A 918 Point Stock Market Crash In Japan
By Michael T. Snyder - Feb 10, 2016

On Tuesday junk bonds continued to crash, the price of oil briefly dipped below 28 dollars a barrel, Deutsche Bank (DE:DBKGn) was forced to deny that it is on the verge of collapse, but the biggest ...

David Trainer
LinkedIn: How Low Can It Go?
By David Trainer - Feb 10, 2016

LinkedIn (N:LNKD: $108/share) has fallen nearly 48% from the beginning of February. Market pundits and analysts are trying to “pick the bottom” largely in an effort to save face. 17 Wall ...